Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Student Policy topic
No spam. Unsubscribe anytime.
Board splits on random drug‑testing policy in first reading of revised student policies
Summary
Trustees discussed policy 5530.01 (random drug testing for students in extracurriculars/parking) during a first reading of the 5000 student policy series. The program has cost about $2,000 for the randomizer, produced roughly 400 tests to date and zero positives; directors and trustees expressed divided views on deterrence, fairness and legal risk.
During first reading of revised student policies on Nov. 24, the Oak Creek‑Franklin board focused discussion on policy 5530.01, the district’s random drug‑testing program for students who sign athletic/activity codes or purchase parking permits.
Policy review committee members and administrators outlined the program’s mechanics and history: the policy was adopted in February 2018, a third‑party vendor randomizes student IDs for testing, and the tests are cheek swabs administered by a medical vendor. Administrators reported about 400 tests since implementation and said there have been no positive results.
Board members were split. Supporters framed the policy as an accountability tool tied to extracurricular privileges. “If you're going to be representing our school, that you're making good choices,” one trustee said in favor. Other trustees cited research and cultural concerns, questioning whether random testing is an effective deterrent and noting those programs are rare in the state. Legal counsel and NEOLA guidance were referenced as considerations for potential liability if the district retains non‑standard policies.
Cost and process details were discussed: the randomizer expense was described as about $2,000, plus administrative steps to notify parents when a student is tested. Administrators described the operational burden as manageable and noted the only negative consequence applied thus far was for one student who refused testing.
The board agreed to consider separating this provision from the broader 5000‑series second reading so trustees can vote specifically on the drug‑testing section at the next meeting.
